Projects per year
Personal profile
Education/Academic qualification
1.6 Biological sciences, Expert, Latvian Council of Science
19 Nov 2019 → 18 Nov 2022
1.6 Biological sciences, Expert, Latvian Council of Science
26 Nov 2016 → 25 Nov 2019
Field of Science
- 3.1 Basic medicine
Fingerprint
Dive into the research topics where Svetlana Kozireva is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 3 Finished
-
Investigation of the chemokine receptors CCR1 and CCR2 and EBV infection aimed on disclosure of new markers that can predict the high risk for progression of chronic lymphocytic leukemia
Holodņuka, I., Kozireva, S., Zvejniece, L., Pavlova, J. & Demida, O.
31/08/18 → 30/11/21
Project: Fundamental and Applied Research Programme
-
Investigation of chemokine receptors CCR1 and CCR2 as potential diagnostic markers of B-cell malignancy progression
Holodņuka, I., Kozireva, S., Bariševs, M., Sultanova, A., Čistjakovs, M. & Lejniece, S.
1/01/14 → 31/12/17
Project: Fundamental and Applied Research Programme
-
Chemokine receptors genes in haematological malignancies
1/01/06 → 31/12/08
Project: Fundamental and Applied Research Programme
-
CHEMOKINE RECEPTORS CCR1 AND CCR2 ARE UP-REGULATED ON CIRCULATING LEUKEMIC CELLS OF THE UNTREATED CD38+ CLL PATIENTS WITH THE HIGH EBV DNA-COPY LOAD
Kholodnyuk, I., Hippe, L., Rivkina, A., Svirskis, S., Sultanova, A., Kozireva, S., Pavlova, J., Murovska, M. & Lejniece, S., 15 Sep 2021, p. 210. 1 p.Research output: Contribution to conference › Abstract › peer-review
-
EPSTEIN BARR VIRUS INFECTION IN NEWLY DIAGNOSED CD38-POSITIVE AND CD38-NEGATIVE PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
Kozireva, S., Zvejniece, L., Rivkina, A., Pavlova, J., Murovska, M., Lejniece, S. & Kholodnyuk, I., 15 Sep 2021, p. 218. 1 p.Research output: Contribution to conference › Abstract › peer-review
-
Expression of the chemokine receptors CCR1 and CCR2 on the circulating leukemic cells of patients with the high-risk chronic lymphocytic leukemia.
Holodnuka, I., Rivkina, A., Zvejniece, L., Demida, O., Svirskis, S., Kozireva, S., Pavlova, J. & Lejniece, S., 13 Dec 2021, p. P-32. 1 p.Research output: Contribution to conference › Abstract › peer-review
-
Inflammatory chemokine receptors in Epstein–Barr virus infection
Holodņuka, I., Kozireva, S., Zvejniece, L., Leonciks, A., Rudevica, Z. & Kashuba, E., 24 Mar 2021, p. 313.Research output: Contribution to conference › Abstract › peer-review
-
Prognostic markers of disease progression in untreated patients with chronic lymphocytic leukemia
Rivkina, A., Kholodnuka, I., Zvejniece, L., Svirskis, S., Soloveicika, M., Kozireva, S., Pavlova, J., Leonciks, A. & Lejniece, S., 24 Mar 2021, p. 121.Research output: Contribution to conference › Abstract › peer-review